Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-4_04-cv-05429/USCOURTS-cand-4_04-cv-05429-42/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 35:271 Patent Infringement

---

MCDERMOTT 

WILL 

& EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

MPK 116371-2.073241.0011

STIP ON L.R. 16-10(B)(8) MEMORANDUM AND 

FOR FILING OBJECTIONS AND TRIAL EXHIBITS

CASE NO. C-04-5429 CW (EMC) 

McDERMOTT WILL & EMERY LLP 

WILLIAM G. GAEDE, III (136184) 

wgaede@mwe.com 

TERRENCE P. McMAHON (71910) 

tmcmahon@mwe.com 

ANDREW A. KUMAMOTO (178541) 

akumamoto@mwe.com 

DAVID L. LARSON (112342) 

dlarson@mwe.com 

3150 Porter Drive 

Palo Alto, CA 94304-1212 

Telephone: (650) 813-5000 

Facsimile: (650) 813-5100 

Attorneys for Tercica, Inc. 

HELLER EHRMAN LLP 

M. PATRICIA THAYER (90818) 

patricia.thayer@hellerehrman.com 

ETHAN C. GLASS (216159) 

ethan.glass@hellerehrman.com 

333 Bush Street 

San Francisco, CA 94104-2878 

Telephone: (415) 772-6794 

Facsimile: (415) 772-6268 

Attorneys for Genentech, Inc. 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA 

OAKLAND DIVISION 

GENENTECH, INC., a Delaware 

Corporation, TERCICA, INC., a Delaware 

Corporation, 

Plaintiffs, 

 v. 

INSMED INCORPORATED, a Virginia 

Corporation, and CELTRIX 

PHARMACEUTICALS, INC., a Delaware 

Corporation, INSMED THERAPEUTIC 

PROTEINS, a Colorado Corporation, 

Defendants. 

No. C-04-5429 CW (EMC) 

STIPULATION ON RULE 16-10(b)(8) 

MEMORANDUM AND FOR FILING OF 

OBJECTIONS AND TRIAL EXHIBITS; 

ORDER 

Pre-trial Conference 

Date: October 27, 2006 

Time: 1:30 p.m. 

Trial Date: November 6, 2006 

Hon. Claudia Wilken 

AND RELATED COUNTERCLAIMS. 

Case 4:04-cv-05429-CW Document 685 Filed 10/18/06 Page 1 of 3
MCDERMOTT 

WILL 

& EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

MPK 116371-2.073241.0011 1 

STIP ON L.R. 16-10(B)(8) MEMORANDUM AND 

FOR FILING OBJECTIONS AND TRIAL EXHIBITS

CASE NO. C-04-5429 CW (EMC)

 For the purpose of expediting and simplifying pre-trial preparation, Genentech Inc. and 

Tercica, Inc. (“Plaintiffs”) and Insmed Incorporated, Celtrix Pharmaceuticals, Inc and Insmed 

Therapeutics Proteins (“Defendants”), through their respective counsel, agree to the following 

stipulations: 

I. STIPULATION FOR DATES OF EXCHANGE OF L.R. 16-10(B)(8) MOTIONS 

AND OPPOSITIONS 

 Plaintiffs and Defendants agree that all opening memorandum under Local Rule 16-

10(B)(8) shall be filed with the Court on October 13, 2006. These memoranda may include the 

following: 

a. Plaintiffs’ motion: Bifurcation of inequitable conduct defense to ‘151 Patent; 

b. Plaintiffs’ motion: Bifurcation and adjudication of defense of misjoinder of 

inventorship to ‘287 Patent; 

c. Plaintiffs’ motion: Adjudication of written description defense to ‘287 Patent; or 

d. Defendants’ motion: Bifurcation of willfulness and damages on all three patentsin-suit; 

 Plaintiffs and Defendants further agree that any oppositions to these motions shall be filed 

with the Court on October 20, 2006. 

II. STIPULATION FOR EXCHANGE OF EXHIBIT LIST AND ITS OBJECTIONS 

AND DEPOSITION DESIGNATIONS AND OBJECTIONS 

 Plaintiffs and Defendants agree that exhibit lists and deposition designations and counterdesignations shall be filed with this Court on October 13, 2006. Plaintiffs and Defendants shall 

exchange (not file or lodge) any objections to the exhibit list and deposition designations on 

October 13, 2006. Once exchanged, Plaintiffs and Defendants shall discuss the objections in a 

meet-and-confer and try and resolve any issues. Plaintiffs and Defendants shall file the final 

exhibit lists and deposition designations with objections that remain after the meet-and-confer 

with the Court on October 20, 2006. Further, Plaintiffs and Defendants shall also file the hard 

copies of all the exhibits with the Court on October 20, 2006. 

Case 4:04-cv-05429-CW Document 685 Filed 10/18/06 Page 2 of 3
MCDERMOTT 

WILL 

& EMERY LLP 

ATTORNEYS AT LAW

PALO ALTO

1 

2 

3 

4 

5 

6 

7 

8 

9 

10 

11 

12 

13 

14 

15 

16 

17 

18 

19 

20 

21 

22 

23 

24 

25 

26 

27 

28 

MPK 116371-2.073241.0011 2 

STIP ON L.R. 16-10(B)(8) MEMORANDUM AND 

FOR FILING OBJECTIONS AND TRIAL EXHIBITS

CASE NO. C-04-5429 CW (EMC)

SO STIPULATED. 

Dated: October 12, 2006 MCDERMOTT WILL & EMERY LLP 

By: /s/ William G. Gaede, III 

William G. Gaede, III 

 Attorneys for Tercica, Inc. 

 HELLER EHRMAN LLP 

By: /s/ M. Patricia Thayer 

M. Patricia Thayer 

Attorneys for Genentech, Inc. 

 FOLEY & LARDNER, LLP 

 By: /s/ Larry L. Shatzer 

Larry L. Shatzer 

Attorneys for Insmed Incorporated, Celtrix 

Pharmaceuticals, Inc., and Insmed 

Therapeutic Proteins, Inc. 

-oOoPURSUANT TO STIPULATION, IT IS SO ORDERED.

 10/18/06 

Dated: 

HONORABLE CLAUDIA WILKEN 

Judge of the United States District Court 

Case 4:04-cv-05429-CW Document 685 Filed 10/18/06 Page 3 of 3